Myriad Genetics partners with SOPHiA GENETICS on liquid biopsy test
Go back to Myriad Genetics partners with SOPHiA GENETICS on liquid biopsy test| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 5.15 +0.02 (0.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.13 | 52 Week High | $45.34 | |||
| Open | $4.96 | 52 Week Low | $15.92 | |||
| Day High | $5.17 | P/E | 2.21 | |||
| Day Low | $4.85 | EPS | $2.33 | |||
| Volume | 1,563,891 | |||||
| (NASDAQ: SOPH) | Delayed: 4.35 +0.02 (0.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.33 | 52 Week High | $ | |||
| Open | $4.40 | 52 Week Low | $ | |||
| Day High | $4.45 | P/E | N/A | |||
| Day Low | $4.21 | EPS | $ | |||
| Volume | 69,136 | |||||

